Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens in Patients With Triple-Class-Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): A KarMMa-3 Analysis in High-Risk Subgroups

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)

引用 0|浏览19
暂无评分
关键词
MM, CAR T, high-risk, triple-class-exposed, progression-free survival
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要